Mencarelli Noemi, Arena Dora, Salamone Marida, Pietrangelo Laura, Berardi Anna C, Cataldi Amelia, Carradori Simone, Gallorini Marialucia
Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, 66100, Chieti, Italy.
IDI Integratori Dietetici Italiani S.r.l., Via G. Mameli 12, 95020, Aci Bonaccorsi, CT, Italy.
Inflamm Res. 2025 Jan 7;74(1):4. doi: 10.1007/s00011-024-01975-5.
This study explores whether hyaluronic acid (HA) of different molecular weights and collagen, given their role in tendon extracellular matrix maintenance, have a synergistic effect on human tendon-derived cells, with the aim to improve the treatment of tendinopathy.
Human monocytes (CRL-9855™) and primary Achilles tendon-derived cells.
The collagen/HA ratio was based on the formulation of the commercial food supplement TendoGenIAL™. The anti-inflammatory activity was evaluated on human lipopolysaccharide (LPS)-stimulated macrophages (24 h) or human Achilles tendon-derived cells under basal and pro-inflammatory conditions (24 and 72 h) and on a co-culture model of tenocytes and inflamed macrophages (24 h).
These data show that the combination of high molecular weight hyaluronic acid and collagen reduces inflammation in macrophages by downregulating CD14, with a mean fluorescence intensity (MFI) of 36,274 (± 1780) (p < 0.0001). Additionally, this combination enhances the modulation of extracellular matrix remodeling proteins, such as CD44 whose MFI is 675,435 (± 28109) (p < 0.00001) and collagen type I at 17.838 µg/mL (± 6,259) (p < 0.00001). The observation of the ultrastructure of tenocytes through electron microscopy reveals increased cell membrane vesiculation and cell size, indicating that tenocytes start to proliferate and create abundant extracellular matrix proteins, important for the matrix remodeling.
Our data confirm the anti-inflammatory activity of both hyaluronic acids and collagen, highlighting a synergistic effect of their combination in a determined ratio.
本研究探讨不同分子量的透明质酸(HA)和胶原蛋白,鉴于它们在肌腱细胞外基质维持中的作用,对人肌腱来源细胞是否具有协同作用,旨在改善肌腱病的治疗。
人单核细胞(CRL-9855™)和原代跟腱来源细胞。
胶原蛋白/HA比例基于商业食品补充剂TendoGenIAL™的配方。在人脂多糖(LPS)刺激的巨噬细胞(24小时)或基础和促炎条件下的人跟腱来源细胞(24和72小时)以及肌腱细胞和炎性巨噬细胞的共培养模型(24小时)上评估抗炎活性。
这些数据表明,高分子量透明质酸和胶原蛋白的组合通过下调CD14降低巨噬细胞中的炎症,平均荧光强度(MFI)为36,274(±1780)(p<0.0001)。此外,这种组合增强了细胞外基质重塑蛋白的调节,如CD44,其MFI为675,435(±28109)(p<0.00001)和I型胶原蛋白为17.838μg/mL(±6,259)(p<0.00001)。通过电子显微镜观察肌腱细胞的超微结构发现细胞膜囊泡化增加和细胞大小增加,表明肌腱细胞开始增殖并产生丰富的细胞外基质蛋白,这对基质重塑很重要。
我们的数据证实了透明质酸和胶原蛋白的抗炎活性,突出了它们以确定比例组合的协同作用。